L-Arginine is an amino acid involved in numerous
areas of human biochemistry, including ammonia detoxification, hormone
secretion, and the immune system. Arginine is also well known as a precursor to
nitric oxide, a key component of endothelial-derived relaxing factor. The
endothelium is the lining inside blood vessels and arginine supplements help
make more nitric oxide. Therefore arginine, by making more nitric oxide, helps to relax and
dilate blood vessels. Nitric oxide is a messenger molecule involved in a variety of endothelium-dependent
effects in the cardiovascular system. Because of arginine's nitric
oxide-stimulating effects, there have been claims that this amino acid is useful in hypertension, preeclampsia, intermittent claudication, and erectile dysfunction.
Arginine has been studied for its role in athletic performance,
burns and trauma, diabetes and syndrome X, male and female infertility, and
interstitial cystitis. What does the research say about the benefit of arginine
supplements for various medical conditions?
Even though arginine supplements have been
claimed to be useful for
some of the conditions listed above, it would be premature to be overly excited.
Much research needs to be done before we
can be more confident about the health benefits of arginine supplements. However,
thus far, arginine
appears to have a role to play in conditions involving blood vessel dilation.
Whether the dilation is short lived or continues for an adequate period is still
being evaluated. Arginine does not appear to be helpful as a supplement taken by
those who have suffered a heart attack. However, some research supports the use
of arginine in heart failure (see below).
As to arginine and erectile function, see below. If you have an interest in
arginine as a sexual enhancer, instead consider Passion Rx which is
significantly more
effective. Passion Rx does not have this amino acid. Prostate Power Rx is also an effective
sexual enhancer.
L Arginine supplement 750 mg, 60 Capsules
Passion Rx, highly effective sexual enhancer

L Arginine is a semi-essential amino acid synthesized by the body from ornithine. This
amino acid supports protein synthesis as it is involved in the transport and
storage of nitrogen. Among many functions, L Arginine is used by the body to produce creatine. Each arginine supplement
capsule contains 750
mg elemental L Arginine.
Usage: Take 1 to 6 arginine supplement capsules daily, or as directed by your qualified health consultant.
Passion Rx - Sexual Enhancer for Men and Women

Passion Rx supports:
In recent years science has made breakthroughs in
the understanding of sexual dysfunction. But, for hundreds of years,
civilizations around the world have known about locally grown herbs that achieve
wonderful results with far fewer side effects than prescription drugs.
Now, renowned physician and herbal
expert Dr. Ray Sahelian, M.D., author of Natural Sex Boosters, has discovered a
combination of exotic herbs from the Amazon jungle, India, China, Malaysia, and
Africa, that provides a natural solution for those seeking an alternative to
synthetic drugs.
The potent herbal extracts and nutrients in Passion Rx include
acetylcarnitine, ashwagandha,
catuaba, cnidium,
horny goat weed,
maca,
mucuna pruriens,
muira puama,
passion flower,
tribulus herb,
tongkat ali and yohimbe. Passion Rx does not contain l arginine.
Another version of Passion Rx is available without yohimbe. Passion Rx does not
contain
Citrulline.
L Arginine and erectile dysfunction
studies
One of the more popular supplements for sexual
dysfunction is L-arginine, also referred to as arginine. Arginine is a versatile amino
acid in animal cells, serving as a precursor for the making not only of proteins but also
of nitric oxide, urea, glutamate, and
creatine. What makes l-arginine
interesting is that it can
be metabolized to nitric oxide (NO). NO is the most powerful chemical known to dilate and
engorge blood vessels in the penis and clitoris. What does the research say
about the role of arginine in
erectile dysfunction?
A
Low dose of l arginine supplement, at 500 mg three times a day,
was not found to be
effective for erectile dysfunction.
A double-blind, placebo-controlled study of 50 men with erectile
dysfunction tested l arginine at a dose of 5 grams per day for six weeks. About a
third of the participants who received l arginine showed improvement, and that
improvement was greater than the 10% improvement seen in the placebo group.
The amino acid L arginine has been studied in combination with other nutrients as a treatment for sexual dysfunction in women. A small trial found some improvement with a combination treatment providing a daily dose of 2,500 mg of l arginine, as well as ginseng, ginkgo, and damiana. In a four-week, double-blind study, 77 women with decreased libido were given either the combination product or a placebo. Those taking the arginine blend showed statistically greater improvement, reporting increased sexual desire in 71% of participants given the treatment. In the placebo group, 42% reported an increased libido. Other improvements included relative satisfaction with sex life and heightened clitoral sensation. No significant side effects were seen in either group. However, we don't know if the arginine had anything to do with the results.
A study done at the University of Texas at Austin examined l arginine benefit, combined with yohimbine, on sexual arousal in postmenopausal women. Twenty-four women participated in three sessions in which sexual responses to erotic stimuli were measured following treatment with either arginine glutamate (6 grams) plus yohimbine (6 mg), yohimbine alone (6 mg), or a placebo. Sexual responses were measured at one hour after taking the supplements. Compared to placebo, the combined oral administration of arginine and yohimbine substantially increased vaginal pulse amplitude responses to the erotic film. It is well known that yohimbine, alone, has a significant effect on sexuality and whether arginine was a factor is not known.
High Quality formulas formulated by a
medical doctor
Consider
highly popular all natural products formulated by a Dr. Ray Sahelian, M.D. These top quality
products include
Mind Power Rx for better
mental focus, concentration, and mood; Diet Rx which helps you eat less. It really does curb appetite; Eyesight
Rx for better vision, often within days; MultiVit
Rx a daily comprehensive multivitamin for more energy and
vitality; Joint Power Rx
for healthy joints; Prostate Power Rx
for a healthy prostate gland.
Mechanism of action
The most likely explanation for the mild effectiveness of l arginine is its
conversion into nitric oxide. As discussed in Chapter 2 of
Natural Sex
Boosters book, nitric oxide is
converted into cGMP, which becomes the secondary messenger that causes smooth
muscle relaxation, resulting in blood vessel dilation, and more blood going into the genital organs, which
leads to erections. However, nitric oxide is quickly metabolized and any
potential l arginine benefit could be short lived.
L Arginine
benefits
There is some supporting evidence that l arginine offers benefits in reducing
angina and lowering blood pressure (see studies bottom of page). Research
indicates supplemental l arginine reduces pulmonary resistance and blood pressure. Arginine supplementation improves renal function in patients with chronic
heart
failure.
Polish researchers have found that arginine supplements increases exercise
tolerance in stable coronary artery disease patients.
Oral L-arginine improves endothelial function in
older healthy individuals. However, I am not convinced yet that arginine is a
worthwhile supplement for erectile function or sexual enhancement, at least when
used in
low dosages.
Benefit of arginine for heart failure
L-arginine supplements may improve the
physical fitness of heart failure patients by enhancing their endurance to
exercise. Dr. Stephane Doutreleau and colleagues from Institut de Physiologie,
Strasbourg, France, examined the potential benefits of 6 weeks of L-arginine
supplements on endurance exercise in 10 patients with chronic stable heart
failure. Patients who took L-arginine
experienced a significant decrease in their average heart rate throughout
exercise and the recovery period. There were no significant changes in blood
pressure and respiratory parameters. The current study supports a prior study in
which a group of heart failure patients were shown to benefit from a combination
of exercise and L-arginine supplements. In that study, the combination appeared
to help correct the abnormal functioning of blood vessels seen in chronic heart
failure. International Journal of Sports Medicine July 2006.
L arginine not helpful in
peripheral artery disease
L-arginine supplementation in peripheral arterial disease: no benefit and
possible harm.
Circulation. 2007 July 10. Wilson AM, Harada R, Nair N, Balasubramanian
N, Cooke JP. Division of Cardiovascular Medicine, Stanford University School of
Medicine, Stanford, California.
L-arginine is the precursor of endothelium-derived nitric oxide, an endogenous
vasodilator. L-arginine supplements improve vascular reactivity and functional
capacity in peripheral arterial disease (PAD) in small, short-term studies. We
aimed to determine the effects of long-term administration of L-arginine on
vascular reactivity and functional capacity in patients with PAD. The Nitric
Oxide in Peripheral Arterial Insufficiency (NO-PAIN) study was a randomized
clinical trial of oral L-arginine (3 grams a day) versus placebo for 6 months in
133 subjects with intermittent claudication due to PAD in a single-center
setting. In patients with peripheral artery disease, long-term administration of
L-arginine does not increase nitric oxide synthesis or improve vascular
reactivity.
Benefit of L arginine
supplements in gestational hypertension
L-arginine supplementation in patients with gestational hypertension: a pilot
study.
Hypertens Pregnancy. 2007. Mother-Infant Dept., Section of Gynaecology
and Obstetrics, University of Modena and Reggio Emilia, Italy.
Patients with gestational hypertension and proteinuria and those without
proteinuria were randomized in a double-blind design to receive either L
arginine (20 grams / 500 mL intravenously daily, for 5 days followed by 4 grams
/day orally for 2 weeks) or placebo. Compared with baseline, both systolic and
diastolic blood pressue 6 days after treatment were significantly reduced in the
l arginine group but not in the placebo group. The treatment with l arginine
seems promising in prolonging pregnancy and reducing blood pressure,
particularly in patients with gestational hypertension and without proteinuria.
L arginine and heart attack
Q. I came across a web site where it says not to take l arginine supplements
following a heart attack (does that apply to recent and old one?) and that six
people had died during an arginine study. I am 66 and have had a heart attack in
1989 and don’t take any drugs for it. I wanted to try an arginine supplement
because of the benefits I have read about, especially erectile dysfunction, and
better circulation, but am now afraid to do so.
A. I have listed the arginine heart attack study below. It would
seem prudent to not use l arginine supplements the first few months after a
heart attack. However, at least one or two additional studies are needed to
determine whether the results of this study regarding the influence of l
arginine supplements and heart attack were coincidence or whether l arginine
does have a negative impact on heart health in those who have had a recent heart
attack.
L-arginine therapy in acute myocardial infarction:
the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI)
randomized clinical trial.
JAMA. 2006 Jan 4. Schulman SP, Becker LC, Kass DA, Champion HC, Terrin
ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, Hare JM,
Gerstenblith G. Division of Cardiology, Johns Hopkins Medical Institutions,
Baltimore, USA.
To determine whether the addition of L-arginine to standard postinfarction
therapy reduces vascular stiffness and improves ejection fraction over 6-month
follow-up in patients following acute ST-segment elevation myocardial
infarction. A total of 153 patients following a first ST-segment elevation
myocardial infarction were enrolled; 77 patients were 60 years or older.
Patients were randomly assigned to receive L-arginine (goal dose of 3 g 3 times
a day) or matching placebo for 6 months. Baseline characteristics, vascular
stiffness measurements, and left ventricular function were similar between
participants randomized to receive placebo or L-arginine. There was no
significant change from baseline to 6 months in the vascular stiffness
measurements or left ventricular ejection fraction in either of the 2 groups,
including those 60 years or older and the entire study group. However, 6
participants (8.6%) in the L-arginine group died during the 6-month study period
vs none in the placebo group. Because of the safety concerns, the data and
safety monitoring committee closed enrollment. L-arginine, when added to
standard postinfarction therapies, does not improve vascular stiffness
measurements or ejection fraction and may be associated with higher
postinfarction mortality.
Dosage
L Arginine is available most often as 750 to 1,000 mg capsules and in powder
form. The dosage of l arginine depends on the condition being treated. In some
cases, an arginine dosage of more than 5 grams a day may be required.
History of L arginine amino acid
L arginine was first isolated in 1886. In 1932, L arginine was found to
be required for the generation of urea, which is necessary for the removal of
toxic ammonia from the body. In 1939 L arginine was also shown to be required
for the synthesis of creatine, the muscle builder.
Arginine deficiency
Symptoms of arginine deficiency include poor wound healing, hair loss,
skin rash, constipation, and fatty liver. Arginine is considered a
semi-essential amino acid, because although it is normally synthesized in
sufficient amounts by the body, arginine supplementation is sometimes required
(for example, due to inborn errors of urea synthesis, protein malnutrition,
excessive lysine intake, burns, peritoneal dialysis, and rapid growth).
L Arginine side effects
I have not come across any significant l arginine side effects up to now.
It is possible that one side effect of high dosage l arginine is nausea. Other
possible side effects on very high dosages are digestive disturbances. I have
personally taken more than 10 grams at one time
at least on three different occasions without any significant adverse effects. But,
it is not clear whether l arginine has side effects if used in high dosages
daily for
many months or years.
It is unlikely that dosages of arginine supplements less
than 3 grams a day would lead to any untoward effects.
L Arginine and nitric oxide
Arginine is a precursor of nitric oxide, which causes blood vessel
relaxation. Although there is some evidence that suggests that arginine
supplements may be
useful in the treatment of medical conditions that are improved by vasodilation,
such as angina, atherosclerosis, coronary artery disease, erectile dysfunction,
heart failure, intermittent claudication / peripheral vascular disease, and
vascular headache, more proof is needed. The appropriate l arginine dosage and long term
safety is not clear at this time. Arginine also stimulates protein synthesis and
has been studied for wound healing, bodybuilding, enhancement of sperm
production (spermatogenesis), and prevention of wasting in people with critical
illness.
Benefit for sexual enhancement
There are many potent herbs that have sexual enhancement properties.
Arginine is not on my top ten list of aphrodisiac supplements and I don't think
a
l arginine health benefit is significant erection enhancement. I prefer the
sex enhancing herbs found in Passion Rx which are much more potent and effective.
Ornithine, arginine, amino acids, and human growth hormone release
Certain amino acids, such as l arginine and ornithine, can stimulate the release of growth hormone when infused intravenously or administered orally. Some individuals ingest amino acids before strength training workouts, thinking that this enhances exercise-induced growth hormone release, thereby promoting greater gains in muscle mass and strength. There is a wide range of response of growth hormone release to amino acid administration between different people. A number of factors are involved including training status, sex, age, medications, other supplements, and diet. Although IV arginine administration consistently leads to increased circulating growth hormone concentration, oral arginine doses that are great enough to induce significant growth hormone release are likely to cause stomach discomfort and diarrhea. During exercise, intensity is a major determinant of growth hormone release. Up to now, studies have not consistently found that pre-exercise oral amino acid supplementation enhances growth hormone release. In addition, no major studies have found that oral supplementation with amino acids such as arginine or ornithine before strength training increases muscle mass and strength to a greater extent than strength training alone. The use of specific amino acids to stimulate growth hormone release by athletes is probably not worthwhile.
Arginine metabolism by the kidneys
The kidney plays a major role in arginine metabolism in 3 principal ways:
arginine synthesis, creatine synthesis, and arginine reabsorption. Arginine is
made in the kidney from citrulline produced by the intestine. The renal enzymes
of arginine synthesis, argininosuccinate synthetase and argininosuccinate lyase,
occur in the cells of the proximal tubule. The rate of arginine synthesis
depends on citrulline delivery and does not appear to be regulated by dietary
arginine availability. Renal arginine synthesis in humans produces approximately
2 grams arginine per day, which may be compared to an intake, from a Western diet, of
approximately 4 to 5 grams a day. Spontaneous, nonenzymatic breakdown of creatine and
creatine phosphate to creatinine causes the excretion of 1 to 2 g creatinine a
day
and requires the replacement of an equivalent amount of creatine from the diet
and by endogenous synthesis. The first enzyme of creatine biosynthesis, L-arginine:glycine
amidinotransferase, occurs in the kidney and produces guanidinoacetate, which is
released into the renal vein. The renal output of guanidinoacetate, however, is
rather low, and we propose that the entire pathway of creatine synthesis may
also occur in the liver. Renal arginine reabsorption salvages approximately 3 grams
of arginine per day. At the apical membrane of proximal tubular cells, arginine shares a
transporter with lysine, ornithine, and cystine. Defects in this heteromeric
transporter cause cystinuria, which is also characterized by urinary loss of
arginine, lysine, and ornithine.
L Arginine research update
L-Arginine supplement improves vascular function by overcoming deleterious effects
of ADMA, a novel cardiovascular risk factor.
Altern Med Rev. 2005 Mar;10(1):14-23.
There is abundant evidence that the endothelium plays a crucial role in
the maintenance of vascular tone and structure. One of the major
endothelium-derived vasoactive mediators is nitric oxide (NO), an endogenous
messenger molecule formed in healthy vascular endothelium from the amino acid
precursor L-arginine. Endothelial dysfunction is caused by various
cardiovascular risk factors, metabolic diseases, and systemic or local
inflammation. One mechanism that explains the occurrence of endothelial
dysfunction is the presence of elevated blood levels of asymmetric
dimethylarginine (ADMA) -- an L arginine analogue that inhibits nitric oxide formation and
thereby can impair vascular function. Supplementation with L-arginine has been
shown to restore vascular function and to improve the clinical symptoms of
various diseases associated with vascular dysfunction
Plasma l arginine concentrations are reduced in cancer patients: evidence
for arginine deficiency?
American Journal of Clinical Nutrition, Vol. 81, No. 5, 1142-1146, May
2005
Preliminary evidence suggests that arginine availability in cancer is reduced.
However, no valid data are available on plasma arginine concentrations in cancer
patients. We aimed to determine whether there is evidence for
disturbed arginine metabolism in cancer. We measured plasma arginine
concentrations postabsorptively in patients with various types of tumors,
hypothesizing that arginine concentrations would be lower than those in age- and
sex-matched control subjects. Patients with localized tumors with a range of
metabolic implications were studied: breast cancer (no weight loss), colonic
cancer (sometimes weight loss), and pancreatic cancer (usually weight loss). Plasma arginine
concentrations were lower in patients with cancer irrespective of tumor type,
weight loss, tumor stage, or body mass index.
Malignant tumors associated with various degrees of metabolic
derangements are all associated with decreased plasma arginine concentrations,
even without weight loss. This suggests that decreased arginine availability is
a specific feature of the presence of cancer. These disturbances in arginine
metabolism could contribute to the cascade of metabolic events leading to cancer
cachexia.
Oral L arginine supplement improves hemodynamic responses to stress and reduces
plasma homocysteine in hypercholesterolemic men.
J Nutr. 2005 Feb;135(2):212-7.
When administered intravenously, the benefit of l arginine supplement is that it substantially reduces blood pressure
(BP) and peripheral vascular resistance in healthy adults and in patients with
vascular disease. Oral l-arginine has been shown to improve endothelial
function; however, it is not clear whether oral administration has significant
effects on systemic hemodynamics. We tested whether oral l-arginine (12 grams
per d for 3 weeks) affected hemodynamics,
glucose, insulin, or C-reactive protein in 16 middle-age men with
high cholesterol. After each treatment, hemodynamic variables were measured
at rest and during 2 standardized stressor tasks (a simulated public-speaking
task and the cold pressor). Regardless of treatment, the stressor tasks
increased BP and heart rate (P </= 0.02). Relative to placebo, l arginine
changed cardiac output, diastolic BP (-1.9 mm Hg), pre-ejection period (+3.4
ms), and plasma homocysteine. The change in plasma l-arginine was inversely
correlated with the change in plasma homocysteine. Contrary to the results of
previous studies of l arginine administered intravenously, oral administration
did not affect total peripheral resistance or plasma insulin. Oral l-arginine
also did not affect plasma glucose, C-reactive protein, or lipids. This pattern
of findings is consistent with the hypothesis that oral l-arginine reduces BP.
This study is the first to describe a hemodynamic mechanism for the hypotensive
effect of oral l arginine and the first to show substantial reductions in
homocysteine with oral administration.
Effect of oral L arginine on oxidant stress, endothelial dysfunction,
and systemic arterial pressure in young cardiac transplant recipients.
Am J Cardiol. 2004 Sep 15;94(6):828-31.
Department of Pediatrics, University of Virginia, Charlottesville, VA
Oral L-arginine therapy reverses endothelial dysfunction and attenuates high
blood pressure in hypertensive cardiac transplant recipients. L-arginine
corrects derangements in the vascular endothelial nitric oxide (NO)-dependent
signaling pathway. Our data support the concept that cardiac transplant
recipients use excess endogenous nitric oxide from L-arginine supplementation to buffer
increased vascular oxidant stress.
Effect of oral L arginine on blood pressure and symptoms and
endothelial function in patients with systemic hypertension, positive exercise
tests, and normal coronary arteries.
Am J Cardiol. 2004 Apr 1;93(7):933-5.
Thirteen hypertensive patients with microvascular angina were studied before
and after receiving oral L-arginine (4 weeks, 2 g, 3 times daily). L-arginine
significantly improved angina class, systolic blood pressure at rest, and
quality of life. Maximal forearm blood flow, plasma L-arginine, L-arginine : asymmetric
dimethyl arginine ratio, and cyclic guanylate monophosphate increased
significantly after treatment. In medically treated hypertensive patients with
micro-vascular angina, oral L-arginine may represent a useful therapeutic
option.
The influence of two different doses of L arginine oral
supplementation on nitric oxide NO concentration and total antioxidant status
(TAS) in atherosclerotic patients.
Med Sci Monit. 2004 Jan;10(1):CR29-32.
The purpose of this study was to assess the effect of two different doses in
28-day L arginine oral supplementation on nitric oxide (NO)
concentration and total antioxidant status (TAS) in patients with
atherosclerotic peripheral arterial disease. 32
patients were divided into 2 groups receiving L-arginine at 3i2 g/day (group A)
or 3i4 g/day (group B). Group A showed substantially higher NO
levels after 14 and 28 days of therapy. In group B, the NO level increase was
substantial after 28 days. Noticeably higher total antioxidant statuses were
noted in both groups: group A showed this only after 28 days of treatment, while
group B exhibited substantial increase in TAS after 7, 14 and 28 days of L-arginine
supplementation. Oral supplementation of L arginine for 28 days
leads to substantial increases in nitric oxide and TAS levels in the blood of patients with atherosclerotic peripheral arterial
disease at Fontaine's stages II and III. The TAS concentration rise points to an antioxidative effect of L arginine oral supplementation.
Treatment of erectile dysfunction with pycnogenol and L arginine.
J Sex Marital Ther. 2003 May-Jun;29(3):207-13.
We investigated the possibility of overcoming
erectile dysfunction by increasing the amounts of endogenous itric oxide. For this
purpose, we orally administered Pycnogenol, because it is known to increase
production of nitric oxide by nitric oxide syntase together with L arginine as substrate
for this enzyme. The study included 40 men, aged 25-45 years, without confirmed
organic erectile dysfunction. Throughout the 3-month trial period, patients
received 3 ampoules Sargenor a day, a drinkable solution of the dipeptide
arginyl aspartate (equivalent to 1.7 g L arginine per day). During the second
month, patients were additionally supplemented with 40 mg Pycnogenol two times
per day; during the third month, the daily dosage was increased to three 40-mg
Pycnogenol tablets. After 1 month of treatment with L arginine, a
statistically nonsignificant number of 2 patients experienced a normal erection.
Treatment with a combination of L arginine and Pycnogenol for the
following month increased the number of men with restored sexual ability to 80%.
Finally, after the third month of treatment, 92% of the men experienced a normal
erection. We conclude that oral administration of L-arginine in combination with
Pycnogenol causes a significant improvement in sexual function in men with
erectile dysfunction without any side effects.
Dietary supplementation with L-arginine or placebo in women with pre-eclampsia.
Staff AC..
Departments of Obstetrics and Gynecology, Ulleval University Hospital,
Kirkeveien 166, Oslo, Norway.
To investigate the effect of dietary intake of the L-arginine
on the diastolic blood pressure in women with pre-eclampsia. A
study was designed to compare the effect of L-arginine
and placebo in pre-eclamptic women. The women received orally 12 grams of L arginine or placebo daily for up
to 5 days. The primary end-point was to identify a difference in diastolic blood
pressure alteration between the two groups after 2 days of intervention. There
was no statistically significant alteration in diastolic blood pressure in the L arginine
group compared with the placebo group after 2 days of treatment.
Oral L arginine supplementation did not reduce mean
diastolic blood pressure after 2 days of treatment compared with placebo in pre-eclamptic
patients with gestational length varying from 28 to 36 weeks.
Adjuvant L-arginine treatment for in-vitro fertilization in poor responder
patients.
Hum Reprod. 1999 Jul;14(7):1690-7.
The objective of the present study was prospectively and randomly to evaluate
the role of L-arginine in improving uterine and follicular Doppler flow and in
improving ovarian response to gonadotrophin in poor responder women. A total of
34 patients undergoing assisted reproduction was divided in two groups according
to different ovarian stimulation protocols: (i) flare-up gonadotrophin-releasing
hormone analogue (GnRHa) plus elevated pure follicle stimulating hormone (pFSH); and (ii) flare-up GnRHa plus elevated pFSH plus oral L-arginine. The plasma and follicular fluid
concentrations of arginine, citrulline, nitrite/nitrate (NO2-/NO3-), and
insulin-like growth factor-1 (IGF-1) were assayed. In the L-arginine treated group a lower cancellation rate, an increased
number of oocytes collected, and embryos transferred were observed. In the same
group, increased plasma and follicular fluid concentrations of arginine,
citrulline, NO2-/NO3-, and IGF-1 was observed. Significant Doppler flow
improvement was obtained in the L arginine supplemented group. Three pregnancies
were registered in these patients. No pregnancies were observed in the other
group. It was concluded that oral L-arginine supplementation in poor responder
patients may improve ovarian response, endometrial receptivity and pregnancy
rate.
Oral L-arginine improves endothelial
function in healthy individuals older than 70 years.
Bode-Boger SM.
University Hospital, Otto-von-Guericke
University, Magdeburg, Germany.
Ageing is associated with progressive endothelial dysfunction in normal humans.
Flow-mediated dilation (FMD) of the brachial artery is impaired in elderly
individuals with cardiovascular disease and vascular nitric oxide (NO)
bioavailability is reduced. We investigated whether oral L arginine, the
substrate for NO synthesis, can improve impaired FMD in healthy very old people.
Twelve healthy old
subjects took L arginine (8 grams orally. two times daily) or
placebo for 14 days each, separated by a wash-out period of 14 days. L-Arginine
significantly improved FMD, whereas placebo had no effect. After L-arginine
supplement use, plasma levels of L-arginine increased significantly, but placebo
had no effect. We conclude that in healthy
very old age endothelial function is impaired and may be improved by oral L-arginine
supplementation.
Practical recommendations for immune-enhancing diets.
J Nutr. 2004 Oct;134(10 Suppl):2868S-2872S; discussion 2895S.
Immune-enhancing diets contain nutrients that have putative benefits, including
arginine, (n-3) fats, glutamine, nucleotides, and structured lipids. Although
under most circumstances the systemic inflammatory response is beneficial to the
host, improving the eventual outcome of injury, infection, or inflammation,
excessive proinflammation (leading to cardiac, hepatic, and mitochondrial
dysfunction) or excessive counterinflammation (leading to immune depression) can
worsen outcome. In critically ill septic patients, the synthesis of arginine can
be exceeded by its catabolism to nitric oxide and urea, rendering arginine
conditionally essential. In patients with sepsis, increased production of nitric
oxide increases serum nitrite and nitrate levels, whereas levels in patients
with trauma and trauma with sepsis are lower than in controls. In septic
patients, arginine supplements might further increase nitric oxide levels and be potentially
harmful through excessive proinflammation. However, administration of increased
amounts of arginine might improve immune function in surgical and trauma
patients by increasing nitric oxide production in macrophages. Thus,
the effects of arginine and (n-3)-fat supplementation might be expected to be
complementary- arginine might improve cytokine and nitric oxide production in patients with immunodepression, whereas (n-3) fats might be beneficial when there is excessive
proinflammation, particularly when supplemental arginine is supplied, by
reducing cytokine-induced eicosanoid production.
Arginine supplement emails
Q. Should a l arginine supplement be taken with meals or on an empty stomach?
A. L Arginine supplements are probably more effective when taken on an empty stomach.
Q. Can I take l arginine regularly for many months?
A. As with most nutrients, I recommend taking breaks from use. In the case of
arginine, it appears to be safe to take for extended periods as long as the dose
is less than 2 grams a day.
Q. Is l arginine better to take as a capsule or powder?
A. It depends on how much you plan to take. If your dose is 1 to 5 g, the capsule
works. If you plan to take more than 5 grams of arginine, then the powder is more efficient.